Evidence map›Paper›PMID 29331340›Full record

ArticleJournal of hepatology2018

Hsp72 protects against liver injury via attenuation of hepatocellular death, oxidative stress, and JNK signaling.

Kateryna Levada, Nurdan Guldiken, Xiaoji Zhang, Giovanna Vella, Fa-Rong Mo, Laura P James, Johannes Haybaeck, Sonja M Kessler, Alexandra K Kiemer, Thomas Ott and 5 more

Open access · greenAbstract read
In one paragraph

Article in Journal of hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Gill Adaptation of the Hong Kong Catfish (Ecology and evolution · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. The JNK signaling pathway in intervertebral disc degeneration.Frontiers in cell and developmental biology · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 5 countries.

Kateryna LevadaDepartment of Internal Medicine III, RWTH University Hospital Aachen, Germany; Interdisciplinary Center for Clinical Research (IZKF), RWTH University Hospital Aachen, Germany; Center for Functionalized Magnetic Materials (FunMagMa), Immanuel Kant Baltic Federal University, Kaliningrad, Russian Federation.
Nurdan GuldikenDepartment of Internal Medicine III, RWTH University Hospital Aachen, Germany; Interdisciplinary Center for Clinical Research (IZKF), RWTH University Hospital Aachen, Germany.
Xiaoji ZhangDepartment of Internal Medicine III, RWTH University Hospital Aachen, Germany; Interdisciplinary Center for Clinical Research (IZKF), RWTH University Hospital Aachen, Germany.
Giovanna VellaDepartment of Internal Medicine III, RWTH University Hospital Aachen, Germany.
Fa-Rong MoDepartment of Internal Medicine III, RWTH University Hospital Aachen, Germany.
Laura P JamesArkansas Children's Hospital Research Institute and Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AK, USA.
Johannes HaybaeckDepartment of Pathology, Medical Faculty, Otto-von-Guericke University Magdeburg, Germany; Institute of Pathology, Medical University of Graz, Graz, Austria.
Sonja M KesslerDepartment of Pharmacy, Pharmaceutical Biology, Saarland University, Saarbrücken, Germany.
Alexandra K KiemerDepartment of Pharmacy, Pharmaceutical Biology, Saarland University, Saarbrücken, Germany.
Thomas OttCore Facility Transgenic Animals, University of Tübingen, Tübingen, Germany.
Daniel HartmannDepartment of Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Norbert HüserDepartment of Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Marianne ZiolPathology Department, GH Paris-Seine-Saint-Denis, APHP, Bondy, France; University Paris 13, Bobigny, France; Centre de Ressources Biologiques - Hôpital Jean Verdier, GH Paris-Seine-Saint-Denis, APHP, Bondy, France.
Christian TrautweinDepartment of Internal Medicine III, RWTH University Hospital Aachen, Germany.
Pavel StrnadDepartment of Internal Medicine III, RWTH University Hospital Aachen, Germany; Interdisciplinary Center for Clinical Research (IZKF), RWTH University Hospital Aachen, Germany. Electronic address: pstrnad@ukaachen.de.
Universitätsklinikum Aachen · DEKlinikum rechts der Isar · DERWTH Aachen University · DESaarland University · DEHôpital Jean-Verdier · FRMedical University of Graz · ATUniversity of Arkansas for Medical Sciences · USUniversity of Tübingen · DE

Funding

Adduct Dipstick for Diagnosis of Acetaminophen ToxicityR42DK079387 · NIDDK · ACETAMINOPHEN TOXICITY DIAGNOSTICS, LLC · PI JAMES, LAURA PHILLIPS · 2011 to 2018
$4.4M
NIDDK NIH HHS R42 DK079387
6 · The paper itself

Abstract

BACKGROUND &

aimsHeat shock protein (Hsp) 72 is a molecular chaperone that has broad cytoprotective functions and is upregulated in response to stress. To determine its hepatic functions, we studied its expression in human liver disorders and its biological significance in newly generated transgenic animals.

methodsDouble transgenic mice overexpressing Hsp72 (gene Hspa1a) under the control of a tissue-specific tetracycline-inducible system (Hsp72-LAP mice) were produced. Acute liver injury was induced by a single injection of acetaminophen (APAP). Feeding with either a methionine choline-deficient (MCD; 8 weeks) or a 3,5-diethoxycarbonyl-1,4-dihydrocollidine-supplemented diet (DDC; 12 weeks) was used to induce lipotoxic injury and Mallory-Denk body (MDB) formation, respectively. Primary hepatocytes were treated with palmitic acid.

resultsPatients with non-alcoholic steatohepatitis and chronic hepatitis C infection displayed elevated HSP72 levels. These levels increased with the extent of hepatic inflammation and HSP72 expression was induced after treatment with either interleukin (IL)-1β or IL-6. Hsp72-LAP mice exhibited robust, hepatocyte-specific Hsp72 overexpression. Primary hepatocytes from these animals were more resistant to isolation-induced stress and Hsp72-LAP mice displayed lower levels of hepatic injury in vivo. Mice overexpressing Hsp72 had fewer APAP protein adducts and were protected from oxidative stress and APAP-/MCD-induced cell death. Hsp72-LAP mice and/or hepatocytes displayed significantly attenuated Jnk activation. Overexpression of Hsp72 did not affect steatosis or the extent of MDB formation.

conclusionsOur results demonstrate that HSP72 induction occurs in human liver disease, thus, HSP72 represents an attractive therapeutic target owing to its broad hepatoprotective functions. LAY SUMMARY: HSP72 constitutes a stress-inducible, protective protein. Our data demonstrate that it is upregulated in patients with chronic hepatitis C and non-alcoholic steatohepatitis. Moreover, Hsp72-overexpressing mice are protected from various forms of liver stress.

Indexed as

Acute-Phase ReactionAnimalsCell DeathChemical and Drug Induced Liver InjuryDisease Models, AnimalFemaleHepatitis C, ChronicHepatocytesHSP72 Heat-Shock ProteinsHumansMaleMallory BodiesMAP Kinase Signaling SystemMiceMice, Inbred C57BLMice, TransgenicHSP72 Heat-Shock ProteinsRecombinant ProteinsDDCDrug-induced injuryJNKLipotoxicityMCD

Identifiers

PMID29331340
PMCPMC9252261
OpenAlexW2783028223

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.